Glaxis Capital Management’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,500	Closed	-$417K	–	46
2024 Q3	$417K	Sell	3,500 -6,500	-65%	-$774K	1.62%	21
2024 Q2	$1.43M	Buy	10,000 +1,000	+11%	+$143K	2.46%	15
2024 Q1	$1.16M	Sell	9,000 -1,000	-10%	-$128K	2.14%	13
2023 Q4	$1.03M	Buy	+10,000	New	+$1.03M	3.6%	9